BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33398392)

  • 1. Correction to: Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.
    Curtis LT; Sebens S; Frieboes HB
    Cancer Immunol Immunother; 2021 May; 70(5):1489. PubMed ID: 33398392
    [No Abstract]   [Full Text] [Related]  

  • 2. Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.
    Curtis LT; Sebens S; Frieboes HB
    Cancer Immunol Immunother; 2021 May; 70(5):1475-1488. PubMed ID: 33180183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell transcriptomics reveals the role of Macrophage-Naïve CD4 + T cell interaction in the immunosuppressive microenvironment of primary liver carcinoma.
    Mo Z; Liu D; Chen Y; Luo J; Li W; Liu J; Yu L; Huang B; Zhang S
    J Transl Med; 2022 Oct; 20(1):466. PubMed ID: 36221095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response.
    Hajiran A; Chakiryan N; Aydin AM; Zemp L; Nguyen J; Laborde JM; Chahoud J; Spiess PE; Zaman S; Falasiri S; Fournier M; Teer JK; Dhillon J; McCarthy S; Moran-Segura C; Katende EN; Sexton WJ; Koomen JM; Mulé J; Kim Y; Manley B
    Clin Exp Immunol; 2021 Apr; 204(1):96-106. PubMed ID: 33346915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational/experimental evaluation of liver metastasis post hepatic injury: interactions with macrophages and transitional ECM.
    Hudson SV; Miller HA; Mahlbacher GE; Saforo D; Beverly LJ; Arteel GE; Frieboes HB
    Sci Rep; 2019 Oct; 9(1):15077. PubMed ID: 31636296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-scale modeling of macrophage-T cell interactions within the tumor microenvironment.
    Cess CG; Finley SD
    PLoS Comput Biol; 2020 Dec; 16(12):e1008519. PubMed ID: 33362239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chamaejasmenin B, an Inhibitor for Metastatic Outgrowth, Reversed M2-Dominant Macrophage Polarization in Breast Tumor Microenvironment.
    Li Q; Sun L; Liu L; Ran Q; Du X; Yang Q; Wang Y; Li Y; Chen Y; Weng X; Cai W; Zhu X
    Front Immunol; 2021; 12():774230. PubMed ID: 35027915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted transcriptional profiling of the tumor microenvironment reveals lymphocyte exclusion and vascular dysfunction in metastatic osteosarcoma.
    Sorenson L; Fu Y; Hood T; Warren S; McEachron TA
    Oncoimmunology; 2019; 8(9):e1629779. PubMed ID: 31428529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis.
    Geng Y; Feng J; Huang H; Wang Y; Yi X; Wei S; Zhang M; Li Z; Wang W; Hu W
    Ann Transl Med; 2022 Nov; 10(21):1170. PubMed ID: 36467341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization.
    Leonard F; Curtis LT; Hamed AR; Zhang C; Chau E; Sieving D; Godin B; Frieboes HB
    Cancer Immunol Immunother; 2020 May; 69(5):731-744. PubMed ID: 32036448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomechanical Contributions to Macrophage Activation in the Tumor Microenvironment.
    Hoffmann EJ; Ponik SM
    Front Oncol; 2020; 10():787. PubMed ID: 32509583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.
    Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Awad S; Dorward N; Grieve J; Mendoza N; Muquit S; Grossman AB; Balkwill F; Korbonits M
    Acta Neuropathol Commun; 2019 Nov; 7(1):172. PubMed ID: 31703742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites.
    Conway JW; Rawson RV; Lo S; Ahmed T; Vergara IA; Gide TN; Attrill GH; Carlino MS; Saw RPM; Thompson JF; Spillane AJ; Shannon KF; Shivalingam B; Menzies AM; Wilmott JS; Long GV; Scolyer RA; Pires da Silva I
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape.
    Ma Y; Guo C; Wang X; Wei X; Ma J
    J Exp Clin Cancer Res; 2023 Sep; 42(1):237. PubMed ID: 37697332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment.
    Jazwinska DE; Kulawiec DG; Zervantonakis IK
    Am J Physiol Cell Physiol; 2023 Sep; 325(3):C721-C730. PubMed ID: 37545408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment.
    Mahlbacher G; Curtis LT; Lowengrub J; Frieboes HB
    J Immunother Cancer; 2018 Jan; 6(1):10. PubMed ID: 29382395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
    Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of CCR2
    Grossman JG; Nywening TM; Belt BA; Panni RZ; Krasnick BA; DeNardo DG; Hawkins WG; Goedegebuure SP; Linehan DC; Fields RC
    Oncoimmunology; 2018; 7(9):e1470729. PubMed ID: 30228938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases.
    Ye J; Guo W; Wang C; Egelston CA; D'Apuzzo M; Shankar G; Fakih MG; Lee PP
    Cancer Res Commun; 2023 Oct; 3(10):2082-2095. PubMed ID: 37768208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
    Stenström J; Hedenfalk I; Hagerling C
    Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.